ECOG PCO-RL: E4206: A Phase II Clinical and Biologic Study of AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors

Project: Research project

Project Details

StatusFinished
Effective start/end date9/16/089/15/16

Funding

  • Frontier Science and Technology Research Foundation (PCOE4206-00)
  • Amgen, Inc. (PCOE4206-00)